Yosuke Terui
Sendai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Reply: The CHECK HEART Score: A Practical Tool for Cardiotoxicity Risk Stratification.
Journal: JACC. Asia
Published: April 16, 2026
Prognostic Impact of Elevated Pulmonary Vascular Resistance in Group 2 Pulmonary Hypertension: Insights From a Japanese Multicenter Registry.
Journal: Journal of the American Heart Association
Published: March 20, 2026
Intractable Ventricular Tachycardia Prior to an Overt Cardiac Tumor Mass of Metastatic Cardiac Rhabdomyosarcoma (Spindle-cell Type).
Journal: Internal medicine (Tokyo, Japan)
Published: November 05, 2023
Pulmonary hypertension in an adult patient with congenital central hypoventilation syndrome: a case report.
Journal: European heart journal. Case reports
Published: October 28, 2023
Usefulness of cardiac magnetic resonance for early detection of cancer therapeutics-related cardiac dysfunction in breast cancer patients.
Journal: International journal of cardiology
Published: May 12, 2022
Beneficial effects of riociguat on hemodynamic responses to exercise in CTEPH patients after balloon pulmonary angioplasty - A randomized controlled study.
Journal: International journal of cardiology. Heart & vasculature
Published: May 24, 2020
Three cases of pulmonary tumor thrombotic microangiopathy (PTTM): Challenge in antemortem diagnosis using lung perfusion blood volume images by dual-energy computed tomography.
Journal: European journal of radiology open
Published: December 08, 2019
Successful Management of Acute Congestive Heart Failure by Emergent Caesarean Section Followed by Adrenalectomy in a Pregnant Woman with Cushing's Syndrome-induced Cardiomyopathy.
Journal: Internal medicine (Tokyo, Japan)
Published: June 28, 2019
Cyclophilin A as a biomarker for the therapeutic effect of balloon angioplasty in chronic thromboembolic pulmonary hypertension.
Journal: Journal of cardiology
Published: June 05, 2019
Prognostic value of the model for end-stage liver disease excluding INR score (MELD-XI) in patients with adult congenital heart disease.
Journal: PloS one
Published: May 20, 2019
Last Updated: 09/26/2026